Fellowship · Richmond, VA
Sponsored by Virginia Commonwealth University Health System
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD.
Hepatology (Baltimore, Md.) · 2022 · 110 citations · Michael Idowu
Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer.
Cancer research · 2023 · 94 citations · Michael Idowu
Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells.
Nature biotechnology · 2025 · 24 citations · Michael Idowu
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.
Blood advances · 2024 · 35 citations · Jeremiah Karrs
Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH.
Journal of hepatology · 2025 · 17 citations · Michael Idowu
A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021 · 75 citations · Michael Idowu
T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy.
Journal for immunotherapy of cancer · 2025 · 16 citations · Michael Idowu
Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
The American journal of surgical pathology · 2023 · 22 citations · Jeremiah Karrs